Moderna Inc

Market cap: $39,384,106,281

Exchange: NAS

Sector: Health Technology

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Key Statistics

Company Name

Moderna Inc

Average Volume (10 days)

4,272,439

Average Volume (30 days)

4,589,449

Moving Average (50 days)

$97.02

Moving Average (200 days)

$93.41

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-8.3547

Market Cap

39,384,106,281

Shares Outstanding

382,073,208

52-Week High Split Adjust Only

163.24

52-Week Low Split Adjust Only

62.55

Employee Count

4,986

Beta

1.1257

Next Earnings Date

2024-05-02

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.03%

Past 30 days

0.18%

Past 3 months

0.2%

Past 6 months

0%

Past year

-0.33%

Past 2 years

-0.42%

Past 5 years

4.15%

Max % Change

4.54%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Moderna IncMRNA27.1919.368.027.1924.41
Peer AvgN/A21.288.87-14.821.2819.97
Johnson & JohnsonJNJ5.296.77n/a5.295.40
Merck & Co IncMRK4.007.1311.74.004.51
Novartis AG - ADRNVS4.374.32n/a4.375.05
Alnylam Pharmaceuticals IncALNY29.2318.02-22.329.2326.57
Arrowhead Pharmaceuticals Inc.ARWR84.7916.96-75.484.7978.31
Regulus Therapeutics IncRGLSn/an/a-3.0n/an/a